CLYDE BIOSCIENCES LIMITED

🌳Matureactive
SC418838 · ltd · incorporated 2012-03-07
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Jul 2024
Net worth
£-1.68M
book net assets
Opportunity
79/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch
What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 79/100 (strong), bankability 75/100. Strong seller-intent signal (63/100, director aged 73). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

🏦

Refinance opportunity

2 live charges · 2 lenders · oldest 8.1y

30/100
under pressure

Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.

  • · Oldest live charge is 8.1 years old — likely at or near maturity.
  • · Two lenders — manageable, but coordination required.
  • · Cashflow trend is negative — lender view likely cautious.

Data confidence

Overall: high (81/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
2 charges (2/2 with lender, 2/2 with type)
90
Directors & officers
14 officers (5 active, 14 linked, 10 with DOB)
84
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
8 connected companies via shared directors
69
Filing history
74 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
79/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
100
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Negative net assets
Liabilities exceed assets by £1,680,195
Cash YoY
-28%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£165k
↓ 28% YoY
Net Worth
-£1.7m
↓ 8.9% YoY
Current Assets
—
Current Liabilities
—
-£1.7m-£1.3m-£917k-£535k-£153k£228kJul 2023Jul 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2024-07-312023-07-31
Cash£164.8k£228.2k
Net assets£-1.68M£-1.54M

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
5
filings
  • • 3 persons-with-significant-control
  • • 2 confirmation-statement
Last 180 days
5
filings
  • • 3 persons-with-significant-control
  • • 2 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (42 events)Click to expand
  1. 2026-03-12
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  2. 2026-03-10
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC02
  3. 2026-03-10
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  4. 2025-04-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2024-04-08
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  6. 2023-04-25
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2022-04-29
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  8. 2022-04-25
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  9. 2022-04-25
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  10. 2022-02-15
    ➕
    MIESSAU, Matthew James appointed
    director
  11. 2022-02-15
    ➖
    FINAN, Peter Michael, Dr resigned
    director
  12. 2021-04-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2020-04-30
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2019-03-25
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2019-03-15
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  16. 2019-02-26
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC05
  17. 2019-02-26
    📄
    change-person-director-company-with-change-date
    officers · CH01
  18. 2019-02-26
    📄
    change-person-director-company-with-change-date
    officers · CH01
  19. 2019-02-25
    ➕
    HENDERSON, Richard David appointed
    director
  20. 2018-11-02
    ➖
    WARDHAUGH, Christopher Thomas resigned
    director
  21. 2018-03-29
    🔒
    Charge registered #2
    Lender: Epidarex Capital Ii, LP
  22. 2018-03-29
    🔒
    Charge registered #1
    Lender: Scottish Enterprise
  23. 2016-07-13
    ➖
    CRAIG, Margaret Anne, Dr resigned
    director
  24. 2015-08-01
    ➕
    JOHNSTON, Alan Mcdougall appointed
    director
  25. 2015-07-29
    ➕
    FINAN, Peter Michael, Dr appointed
    director
  26. 2015-03-20
    ➕
    DUNLOP, Andrew Sinclair appointed
    director
  27. 2015-03-20
    ➖
    BEAUMONT, Steven Peter, Professor resigned
    director
  28. 2015-03-20
    ➕
    WARDHAUGH, Christopher Thomas appointed
    director
  29. 2013-10-09
    ➖
    IP2IPO SERVICES LIMITED resigned
    corporate-director
  30. 2012-09-29
    ➕
    IP2IPO SERVICES LIMITED appointed
    corporate-director
  31. 2012-07-04
    ➕
    SMITH, Godfrey, Professor appointed
    director
  32. 2012-07-04
    ➖
    D.W. COMPANY SERVICES LIMITED resigned
    corporate-secretary
  33. 2012-07-04
    ➕
    BEAUMONT, Steven Peter, Professor appointed
    director
  34. 2012-07-04
    ➕
    CRAIG, Margaret Anne, Dr appointed
    director
  35. 2012-07-04
    ➖
    ROSE, Kenneth Charles resigned
    director
  36. 2012-07-04
    ➖
    D.W. COMPANY SERVICES LIMITED resigned
    corporate-director
  37. 2012-07-04
    ➖
    D.W. DIRECTOR 1 LIMITED resigned
    corporate-director
  38. 2012-03-07
    🏢
    Company incorporated
    As CLYDE BIOSCIENCES LIMITED
  39. 2012-03-07
    ➕
    D.W. COMPANY SERVICES LIMITED appointed
    corporate-secretary
  40. 2012-03-07
    ➕
    ROSE, Kenneth Charles appointed
    director
  41. 2012-03-07
    ➕
    D.W. COMPANY SERVICES LIMITED appointed
    corporate-director
  42. 2012-03-07
    ➕
    D.W. DIRECTOR 1 LIMITED appointed
    corporate-director

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -5 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 73 — succession pressure is live.

Succession & seller-readiness

73/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 70+: Senior director is approximately 73 years old. Natural succession window is now.
  • secondary12+ year tenure: Director in role 14 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Epidarex Capital Partners Limited holds majority control (50-75%). Likely parent but not wholly-owned.

🏛️
Epidarex Capital Partners Limited
Corporate parent · holds 50-75% shares
majority
⬇
CLYDE BIOSCIENCES LIMITED
This company · SC418838

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Epidarex Capital Partners Limited
Corporate entity
50–75%
50–75%50-75% shares · 50-75% voting16/03/2021
1 historic (ceased) PSC
  • Epidarex Capital Management Llpceased 21/03/2021· 25-50% shares · 25-50% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · ML postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
CLYDE & AVONDALE ASSOCIATES LTD.→
SC457450 · est 2013 · no financials extracted
————12y——
CMC ACCOUNTANCY LTD→
SC777768 · est 2023 · no financials extracted
————2y——
CMM COMMISSIONING & COMPLETIONS LTD→
SC576965 · est 2017 · no financials extracted
————8y——
CNC SERVICES (SCOTLAND) LTD.→
SC275373 · est 2004 · no financials extracted
————21y——
COMPASS AVIATION SOLUTIONS LIMITED→
SC757442 · est 2023 · no financials extracted
————3y——
COSMIC ENGINEERING LTD→
SC807847 · est 2024 · no financials extracted
————1y——
COWAN CLINICAL LTD→
SC435556 · est 2012 · no financials extracted
————13y——
CP PROPERTIES LTD→
SC522051 · est 2015 · no financials extracted
————10y——
CREECHAN ACCOUNTANCY SERVICES LIMITED→
SC554642 · est 2017 · no financials extracted
————9y——
CRK CONSULTANTS LTD.→
SC699996 · est 2021 · no financials extracted
————4y——
DARCY HOLDINGS LTD→
SC879884 · est 2026 · no financials extracted
———————
DARKMATTER OPERATIONS LTD→
SC655666 · est 2020 · no financials extracted
————6y——
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2012-03-07
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

Biocity Scotland
Bo'Ness Road
Motherwell
Lanarkshire
ML1 5UH
Scotland

Filing status

Accounts
Next due: 2026-04-30
Last made up to: 2024-07-31
Confirmation statement
Next due: 2027-03-12
Last: 2026-02-26

Officers (5 active · 9 resigned)

DUNLOP, Andrew Sinclair→
director · ~54y · appointed 2015-03-20
View their other companies + combined net worth →
Active
HENDERSON, Richard David→
director · ~60y · appointed 2019-02-25
View their other companies + combined net worth →
Active
JOHNSTON, Alan Mcdougall→
director · ~73y · appointed 2015-08-01
View their other companies + combined net worth →
Active
MIESSAU, Matthew James→
director · ~38y · appointed 2022-02-15
View their other companies + combined net worth →
Active
SMITH, Godfrey, Professor→
director · ~69y · appointed 2012-07-04
View their other companies + combined net worth →
Active
D.W. COMPANY SERVICES LIMITED→
corporate-secretary · appointed 2012-03-07 · resigned 2012-07-04
Resigned
BEAUMONT, Steven Peter, Professor→
director · ~74y · appointed 2012-07-04 · resigned 2015-03-20
Resigned
CRAIG, Margaret Anne, Dr→
director · ~55y · appointed 2012-07-04 · resigned 2016-07-13
Resigned
FINAN, Peter Michael, Dr→
director · ~59y · appointed 2015-07-29 · resigned 2022-02-15
Resigned
ROSE, Kenneth Charles→
director · ~63y · appointed 2012-03-07 · resigned 2012-07-04
Resigned
WARDHAUGH, Christopher Thomas→
director · ~56y · appointed 2015-03-20 · resigned 2018-11-02
Resigned
D.W. COMPANY SERVICES LIMITED→
corporate-director · appointed 2012-03-07 · resigned 2012-07-04
Resigned
D.W. DIRECTOR 1 LIMITED→
corporate-director · appointed 2012-03-07 · resigned 2012-07-04
Resigned
IP2IPO SERVICES LIMITED→
corporate-director · appointed 2012-09-29 · resigned 2013-10-09
Resigned

Click a director name to see their full track record across all companies.

Mortgages & charges

2
Total charges
2
Outstanding
2
Active lenders
Status:Lender:2 of 2 shown
TypeProperties
outstanding
Epidarex Capital Ii, LP
A registered charge—29/03/2018—
outstanding
Scottish Enterprise
A registered charge—29/03/2018—
Click column headers to sort. Use filters above to narrow by status and lender.

Recent filings (74 total)

cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-12
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC02
2026-03-10
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-10
confirmation-statement-with-updates
confirmation-statement · CS01
2026-02-26
confirmation-statement-with-updates
confirmation-statement · CS01
2026-02-12
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-04-30
confirmation-statement-with-updates
confirmation-statement · CS01
2025-02-11
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-04-08
confirmation-statement-with-updates
confirmation-statement · CS01
2024-03-07
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-04-25
confirmation-statement-with-updates
confirmation-statement · CS01
2023-02-09
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-04-29
appoint-person-director-company-with-name-date
officers · AP01
2022-04-25
termination-director-company-with-name-termination-date
officers · TM01
2022-04-25
confirmation-statement-with-updates
confirmation-statement · CS01
2022-03-25